Background: In patients with native coronary artery disease, strong evidence supports the
use of statins to reduce the risk of recurrent cardiovascular events and improve survival …

Statins clearly improve the outcomes of CABG patients. In the absence of contraindications,
all patients undergoing CABG are candidates for life-long statin therapy, with initiation …

Background—Statin therapy in nonsurgical patient populations is associated with a
significant reduction in adverse cardiovascular events, including death, myocardial infarction …

OBJECTIVE: The aim of this study was to determine whether perioperative statin therapy
was associated with a dose-dependent decrease in adverse cardiovascular events after …

OBJECTIVE: Statin therapy in ambulatory populations is associated with a significant
reduction in adverse cardiovascular events, including death and myocardial infarction. Much …

Statin therapy prevents the first occurrence and recurrence of coronary events and reduces
cardiovascular and general mortality in patients with coronary artery disease. These …

Objective The objective of this study was to evaluate the association of statin use after
coronary artery bypass grafting (CABG) and long-term adverse events in a large population …

OBJECTIVE: Statins might have pleiotropic effects, independent of their ability to reduce lipid
levels. Recent data have suggested that statins improve early survival and cardiovascular …

OBJECTIVES: The benefits of statin therapy for patients with coronary artery disease have
been well documented, including those occurring after coronary artery bypass graft surgery …

Background Statins are widely prescribed to patients with atherosclerosis. A retrospective
database analysis was used to examine the role of preoperative statin use in hospital …